Global Percutaneous Coronary Intervention Market, By Product Type (Coronary Stents, PTCA Catheters, Coronary Guidewire, Accessories), By End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Research and Academic Institutes, Others), and opportunities and forecast 2020-2027
Percutaneous coronary intervention (PCI) refers to a family of minimally invasive procedures used to open clogged coronary arteries (those that deliver blood to the heart). By restoring blood flow, the treatment can improve symptoms of blocked arteries, such as chest pain or shortness of breath. The global Percutaneous Coronary Intervention market is projected to grow at a considerable rate in the coming years.
In recent years, the rise in the prevalence of heart disease has been regarded as one of the leading causes of death in both men and women. PCI is a procedure that is used to treat acute heart attacks, ease angina (chest discomfort), prevent heart attacks, and treat congestive heart failure, among other things. Because of the rising frequency of coronary heart disease, PCI has become increasingly important in recent years. According to World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
Over the forecast period, factors such as the rising frequency of cardiac disorders, the rising preference for minimally invasive procedures, and the growing geriatric population that is more sensitive to these diseases are expected to drive market expansion. However, the procedure's strict regulatory requirements may restrict the market's expansion.
Report Metric
Details
Market size available for years
2019–2027
Base year considered
2019
Forecast period
2020–2027
Forecast unit
Value (USD Million)
Segments covered
Product Type, End User, and Region.
Regions covered
North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered
Abbott, ASAHI INTECC Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK, Boston Scientific Corporation, C. R. Bard, Inc., Comed BV, Cook, Cordis, Medtronic PLC, Meril Lifesciences Pvt. Ltd, Merit Medical System, Terumo Corporation.
Covid-19 Impact on Percutaneous Coronary Intervention Market
In addition, the current Percutaneous Coronary Intervention Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Percutaneous Coronary Intervention Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Based on Product Type, Coronary Stents is one of the major segments in the global Percutaneous Coronary Intervention market. A coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI). Coronary stents are now used in more than 90% of PCI procedures.
Percutaneous Coronary Intervention Market, By Product Type · Coronary Stents · PTCA Catheters · Coronary Guidewire · Accessories
Percutaneous Coronary Intervention Market, By End User · Hospitals & Specialty Clinics · Ambulatory Surgical Centers · Research and Academic Institutes · Others
The global Percutaneous Coronary Intervention market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share in the global Percutaneous Coronary Intervention market. It is predicted that this region shows remarkable growth in the estimated period. This is primarily due to the mounting awareness and the growing acceptability of percutaneous coronary intervention techniques. Europe is the second-largest region for the market. The factors responsible for market growth in this region are an increased number of hospitalizations for percutaneous coronary intervention techniques such as carotid artery angioplasty and cerebral angioplasty. Moreover, the market in the Asia Pacific is projected to grow at a considerable rate in the coming years. This is due to the growing prevalence of cardiovascular diseases coupled with developing healthcare infrastructure and rising disposable income.
Percutaneous Coronary Intervention Market, By Geography
· North America (US & Canada) · Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe) · Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific) · LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
· Abbott · ASAHI INTECC Company Limited · B. Braun Melsungen AG · Biosensors International Group, Ltd · BIOTRONIK · Boston Scientific Corporation · C. R. Bard, Inc. · Comed BV · Cook · Cordis · Medtronic PLC · Meril Lifesciences Pvt. Ltd · Merit Medical System · Terumo Corporation
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Percutaneous Coronary Intervention market?
A. Factors such as the rising frequency of cardiac disorders, the rising preference for minimally invasive procedures, and the growing geriatric population that is more sensitive to these diseases are expected to drive market expansion
Q2. What are the restraining factors for the global Percutaneous Coronary Intervention market?
A. The procedure's strict regulatory requirements may restrict the market's expansion
Q3. Which segment is projected to hold the largest share in the global Percutaneous Coronary Intervention Market?
A. Coronary Stents segment is projected to hold the largest share in the global Percutaneous Coronary Intervention Market.
Q4. Which region holds the largest share in the global Percutaneous Coronary Intervention market?
A. North America held the largest share in the global Percutaneous Coronary Intervention market
Q5. Which are the prominent players in the global Percutaneous Coronary Intervention Market?
A. Abbott, ASAHI INTECC Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK, Boston Scientific Corporation, C. R. Bard, Inc., Comed BV, Cook, Cordis, Medtronic PLC, Meril Lifesciences Pvt. Ltd, Merit Medical System, Terumo Corporation. are some key players in the global Percutaneous Coronary Intervention Market.
Percutaneous Coronary Intervention Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Key Emerging Trends – For Major Countries
4.2. Latest Technological Advancement
4.3. Regulatory Landscape
4.4. Industry SWOT Analysis
4.5. Porters Five Forces Analysis
5. Global Percutaneous Coronary Intervention Market Analysis (USD Billion), Insights and Forecast, 2020-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product Type
5.2.1. Coronary Stents
5.2.2. PTCA Catheters
5.2.3. Coronary Guidewire
5.2.4. Accessories
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1. Hospitals & Specialty Clinics
5.3.2. Ambulatory Surgical Centers
5.3.3. Research and Academic Institutes
5.3.4. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America, Middle East and Africa
6. North America Percutaneous Coronary Intervention Market Analysis (USD Billion), Insights and Forecast, 2020-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Product Type
6.2.1. Coronary Stents
6.2.2. PTCA Catheters
6.2.3. Coronary Guidewire
6.2.4. Accessories
6.3. Market Analysis, Insights and Forecast – By End User
6.3.1. Hospitals & Specialty Clinics
6.3.2. Ambulatory Surgical Centers
6.3.3. Research and Academic Institutes
6.3.4. Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Percutaneous Coronary Intervention Market Analysis (USD Billion), Insights and Forecast, 2020-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Product Type
7.2.1. Coronary Stents
7.2.2. PTCA Catheters
7.2.3. Coronary Guidewire
7.2.4. Accessories
7.3. Market Analysis, Insights and Forecast – By End User
7.3.1. Hospitals & Specialty Clinics
7.3.2. Ambulatory Surgical Centers
7.3.3. Research and Academic Institutes
7.3.4. Others
7.4. Market Analysis, Insights and Forecast – By Country
7.4.1. UK
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Rest of Europe
8. Asia Pacific Percutaneous Coronary Intervention Market Analysis (USD Billion), Insights and Forecast, 2020-2027
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Product Type
8.2.1. Coronary Stents
8.2.2. PTCA Catheters
8.2.3. Coronary Guidewire
8.2.4. Accessories
8.3. Market Analysis, Insights and Forecast – By End User
8.3.1. Hospitals & Specialty Clinics
8.3.2. Ambulatory Surgical Centers
8.3.3. Research and Academic Institutes
8.3.4. Others
8.4. Market Analysis, Insights and Forecast – By Country
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Australia
8.4.5. South East Asia
8.4.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Percutaneous Coronary Intervention Market Analysis (USD Billion), Insights and Forecast, 2020-2027
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Product Type
9.2.1. Coronary Stents
9.2.2. PTCA Catheters
9.2.3. Coronary Guidewire
9.2.4. Accessories
9.3. Market Analysis, Insights and Forecast – By End User
9.3.1. Hospitals & Specialty Clinics
9.3.2. Ambulatory Surgical Centers
9.3.3. Research and Academic Institutes
9.3.4. Others
9.4. Market Analysis, Insights and Forecast – By Country
9.4.1. Brazil
9.4.2. Saudi Arabia
9.4.3. UAE
9.4.4. Rest of LAMEA
10. Competitive Analysis
10.1. Company Market Share Analysis, 2018
10.2. Key Industry Developments
10.3. Company Profile
10.4. Abbott
10.4.1. Business Overview
10.4.2. Segment 1 & Service Offering
10.4.3. Overall Revenue
10.4.4. Geographic Presence
10.4.5. Recent Development
*Similar details will be provided for the following companies
10.5. ASAHI INTECC Company Limited
10.6. B. Braun Melsungen AG
10.7. Biosensors International Group, Ltd
10.8. BIOTRONIK
10.9. Boston Scientific Corporation
10.10. C. R. Bard, Inc.
10.11. Comed BV
10.12. Cook
10.13. Cordis
10.14. Medtronic PLC
10.15. Meril Lifesciences Pvt. Ltd
10.16. Merit Medical System
List of Figures
Figure 1: Global Percutaneous Coronary Intervention Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Percutaneous Coronary Intervention Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Percutaneous Coronary Intervention Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Percutaneous Coronary Intervention Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Percutaneous Coronary Intervention Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Percutaneous Coronary Intervention Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Percutaneous Coronary Intervention Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Percutaneous Coronary Intervention Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Percutaneous Coronary Intervention Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Percutaneous Coronary Intervention Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Percutaneous Coronary Intervention Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Percutaneous Coronary Intervention Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Percutaneous Coronary Intervention Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027
